Anti-angiogenic active immunotherapy: a new approach to cancer treatment Jianping PanPengfeng JinDieter Kabelitz Review 24 January 2008 Pages: 1105 - 1114
The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients Takuya OsadaGabriel ChongMichael A. Morse Original Article 10 January 2008 Pages: 1115 - 1124
Different immune correlates associated with tumor progression and regression: implications for prevention and treatment of cancer Duane H. HamiltonPeter A. Bretscher Original Article 10 January 2008 Pages: 1125 - 1136
Activation of extracellular signaling regulated kinase in natural killer cells and monocytes following IL-2 stimulation in vitro and in patients undergoing IL-2 immunotherapy: analysis via dual parameter flow-cytometric assay Sri Vidya KondadasulaKimberly A. VarkerWilliam E. Carson III Original Article 10 January 2008 Pages: 1137 - 1149
CD40 ligation in vivo can induce T cell independent antitumor effects even against immunogenic tumors Alexander L. RakhmilevichIlia N. BuhtoiarovPaul M. Sondel Original Article 24 January 2008 Pages: 1151 - 1160
Delivery of mengovirus-derived RNA replicons into tumoural liver enhances the anti-tumour efficacy of a peripheral peptide-based vaccine Jean-Pierre CoutyAnne-Marie CrainMireille Viguier Original Article 07 February 2008 Pages: 1161 - 1171
Use of radiolabeled monoclonal antibody to enhance vaccine-mediated antitumor effects Mala ChakrabortyAlexander GelbardJames W. Hodge Original Article 07 February 2008 Pages: 1173 - 1183
Recognition of naturally processed and ovarian cancer reactive CD8+ T cell epitopes within a promiscuous HLA class II T-helper region of NY-ESO-1 Junko MatsuzakiFeng QianKunle Odunsi Original Article 06 February 2008 Pages: 1185 - 1195
TGFβ secreted by B16 melanoma antagonizes cancer gene immunotherapy bystander effect Claudia PenafuerteJacques Galipeau Original Article 24 January 2008 Pages: 1197 - 1206
Serum antibodies against Saccharomyces cerevisiae: a new prognostic indicator in metastatic renal-cell carcinoma Reinhold RamonerAndrea RahmMartin Thurnher Original Article 06 March 2008 Pages: 1207 - 1214
Sequence uniqueness and sequence variability as modulating factors of human anti-HCV humoral immune response Darja KanducLuciana TessitoreFrancesco M. Marincola Original Article 07 February 2008 Pages: 1215 - 1223
Preclinical studies in rats and squirrel monkeys for safety evaluation of the bivalent anti-human T cell immunotoxin, A-dmDT390–bisFv(UCHT1) Jung Hee WooSarah H. BourArthur E. Frankel Original Article 07 February 2008 Pages: 1225 - 1239
The anti-tumor agent, ingenol-3-angelate (PEP005), promotes the recruitment of cytotoxic neutrophils by activation of vascular endothelial cells in a PKC-δ dependent manner Peter HampsonDean KavanaghG. Ed Rainger Original Article 12 February 2008 Pages: 1241 - 1251
The neoplastically transformed (CD30hi) Marek’s disease lymphoma cell phenotype most closely resembles T-regulatory cells L. A. ShackJ. J. BuzaS. C. Burgess Original Article 07 February 2008 Pages: 1253 - 1262
Local secretion of anti-CTLA-4 enhances the therapeutic efficacy of a cancer immunotherapy with reduced evidence of systemic autoimmunity Andrew D. SimmonsMarina MoskalenkoKarin Jooss Short Communication 31 January 2008 Pages: 1263 - 1270